These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26939231)

  • 1. NON-INVASIVE PREDICTORS OF PORTAL HYPERTENSION IN PATIENTS WITH HEPATITIS C VIRUS RELATED HEPATOCELLULAR CARCINOMA.
    Mohran Z; Sakr M; Barakat E; Elbaz A; Al-Hamid MA; Abou-Elmaaty M
    J Egypt Soc Parasitol; 2015 Dec; 45(3):545-54. PubMed ID: 26939231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma.
    Iranmanesh P; Vazquez O; Terraz S; Majno P; Spahr L; Poncet A; Morel P; Mentha G; Toso C
    J Hepatol; 2014 May; 60(5):969-74. PubMed ID: 24362073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.
    Afdhal N; Everson GT; Calleja JL; McCaughan GW; Bosch J; Brainard DM; McHutchison JG; De-Oertel S; An D; Charlton M; Reddy KR; Asselah T; Gane E; Curry MP; Forns X
    J Viral Hepat; 2017 Oct; 24(10):823-831. PubMed ID: 28295923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma.
    Rajakannu M; Cherqui D; Ciacio O; Golse N; Pittau G; Allard MA; Antonini TM; Coilly A; Sa Cunha A; Castaing D; Samuel D; Guettier C; Adam R; Vibert E
    Surgery; 2017 Oct; 162(4):766-774. PubMed ID: 28711320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
    Pind ML; Bendtsen F; Kallemose T; Møller S
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):948-54. PubMed ID: 27172450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis.
    Choi SY; Jeong WK; Kim Y; Kim J; Kim TY; Sohn JH
    Radiology; 2014 Dec; 273(3):917-26. PubMed ID: 25025464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A non-invasive magnetic resonance imaging-based model predicts portal venous pressure.
    Zhang QW; Wang Y; Wang J; Zhao HB; Yu H; Liu SY; Zeng X; Chen Q; Hu ZQ; Guo WY; Fu ZR; Ding GS; Shi XY; Xie WF
    J Dig Dis; 2016 Mar; 17(3):175-85. PubMed ID: 26860821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic venous pressure gradient determination in patients with hepatitis C virus-related and alcoholic cirrhosis.
    Bellis L; Castellacci R; Montagnese F; Festuccia F; Corvisieri P; Puoti C
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1085-9. PubMed ID: 14501616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices.
    Lee E; Kim YJ; Goo DE; Yang SB; Kim HJ; Jang JY; Jeong SW
    World J Gastroenterol; 2016 Mar; 22(11):3212-9. PubMed ID: 27003998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C
    J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver stiffness-based model for portal hypertension and hepatocellular cancer risk in HBV responsive to antivirals.
    Marzano A; Tucci A; Chialà C; Saracco GM; Fadda M; Debernardi Venon W
    Minerva Gastroenterol Dietol; 2019 Mar; 65(1):11-19. PubMed ID: 30356037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
    Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients.
    Sánchez-Conde M; Miralles P; Bellón JM; Rincón D; Ramírez M; Gutiérrez I; Ripoll C; López JC; Cosín J; Clemente G; Lo Iacono O; Bañares R; Berenguer J
    J Viral Hepat; 2011 Oct; 18(10):685-91. PubMed ID: 21914085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.
    Colecchia A; Montrone L; Scaioli E; Bacchi-Reggiani ML; Colli A; Casazza G; Schiumerini R; Turco L; Di Biase AR; Mazzella G; Marzi L; Arena U; Pinzani M; Festi D
    Gastroenterology; 2012 Sep; 143(3):646-654. PubMed ID: 22643348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
    Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma.
    Stremitzer S; Tamandl D; Kaczirek K; Maresch J; Abbasov B; Payer BA; Ferlitsch A; Gruenberger T
    Br J Surg; 2011 Dec; 98(12):1752-8. PubMed ID: 22009385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic venous pressure gradient: worth another look?
    Parikh S
    Dig Dis Sci; 2009 Jun; 54(6):1178-83. PubMed ID: 18975087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.